解决孤儿药的授权问题并不能解决报销问题：大象仍在房间里。（此译文保留了原文的隐喻表述，“大象仍在房间里”意思是关键问题依然存在未得到解决） - Suppr

Suppr

超能文献

Addressing the authorization of orphan drugs will not fix reimbursement problems: The elephant is still in the room.

作者信息

Embrett Mark

机构信息

Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, Ontario.

出版信息

Can Pharm J (Ott). 2013 Sep;146(5):245-6. doi: 10.1177/1715163513499127.

DOI:10.1177/1715163513499127

PMID:24093029

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3785191/

Abstract

摘要

相似文献

Addressing the authorization of orphan drugs will not fix reimbursement problems: The elephant is still in the room.

Can Pharm J (Ott). 2013 Sep;146(5):245-6. doi: 10.1177/1715163513499127.

Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment.

Front Pharmacol. 2018 Nov 12;9:1263. doi: 10.3389/fphar.2018.01263. eCollection 2018.

[Authorization and reimbursement of orphan drugs in an international comparison].

Gesundheitswesen. 2011 Aug;73(8-9):504-14. doi: 10.1055/s-0030-1262864. Epub 2010 Sep 16.

Critical assessment of belgian reimbursement dossiers of orphan drugs.

Pharmacoeconomics. 2011 Oct;29(10):883-93. doi: 10.2165/11585980-000000000-00000.

Availability of and access to orphan drugs: an international comparison of pharmaceutical treatments for pulmonary arterial hypertension, Fabry disease, hereditary angioedema and chronic myeloid leukaemia.

Pharmacoeconomics. 2011 Jan;29(1):63-82. doi: 10.2165/11539190-000000000-00000.

Access to orphan drugs despite poor quality of clinical evidence.

Br J Clin Pharmacol. 2011 Apr;71(4):488-96. doi: 10.1111/j.1365-2125.2010.03877.x.

An Overview of the Orphan Medicines Market in Turkey.

Value Health Reg Issues. 2014 Sep;4:47-52. doi: 10.1016/j.vhri.2014.06.009. Epub 2014 Jul 30.

[European ordinance on orphan drugs: changes and threats].

Ned Tijdschr Geneeskd. 2003 Jan 25;147(4):143-5.

Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries.

Front Pharmacol. 2019 Nov 27;10:1279. doi: 10.3389/fphar.2019.01279. eCollection 2019.

[Orphan diseases and orphan medicines: a Belgian and European study].

J Pharm Belg. 2009 Dec(4):131-7.

引用本文的文献

Translating rare-disease therapies into improved care for patients and families: what are the right outcomes, designs, and engagement approaches in health-systems research?

Genet Med. 2016 Feb;18(2):117-23. doi: 10.1038/gim.2015.42. Epub 2015 Apr 9.

本文引用的文献

Qualitative evaluation of the Canadian Fabry Disease Initiative.

Can Pharm J (Ott). 2012 May;145(3):136-141.e3. doi: 10.3821/145.3.cpj136.

The National Pharmaceuticals Strategy: Rest in peace, revive or renew?

CMAJ. 2009 Apr 14;180(8):801-3. doi: 10.1503/cmaj.082087. Epub 2009 Feb 3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验